Open original FDA record ↗Recall record
- FDA identifier
- Z-0981-2014
- Company in FDA record
- GE Healthcare, LLC
- FDA classification date
- Feb 14, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
GE Healthcare has recently become aware of a potential safety issue due to scatter overcorrection associated with the List Mode Replay feature of your Discovery 600, 610, 710 and Discovery 690.
Source facts
- Action
- GE Healthcare sent an Urgent Medical Device Correction letter dated November 20, 2013, and December 4, 2013, to all affected consignees. The letters described the Safety Issue, Safety Instructions, Affected Products Details, Product Correction and Contact Information ( In the US Call 1-800-437-1171. For other countries contact your local GE Healthcare Service Representative). Customers were given the following instructions: To avoid potential issues, replay the list mode data prior to another acquisition. In the event another acquisition is made before replaying the list data, or following reboot, do the following steps: Perform a PET only acquisition using the same tracer that is intended for the List Mode Replay. Then, proceed to perform the List Mode Replay and subsequent reconstructions. Make sure to perform a quality check on any images created after any replay of data. Affected Product Details PET Discovery 610 and PET Discovery 710, with software versions pet_coreload.44 and pet_mfk.44. The software version is visible on the homepage of the service desktop. To determine the software version currently on your system, do the following: 1. On the right monitor upper left corner select the Service Icon. 2. Verify that the Service window is under Home. 3. Locate the SW Build Version listed in the center of the page. For questions regarding this recall call 800-437-1171.
- Initiated
- 2013-11-20
- Root cause
- Software Manufacturing/Software Deployment
- Terminated
- 2014-07-29
- Distribution
- Worldwide Distribution - USA including AL, AZ, AR, CA, CO, FL, GA, IL, IN, IA, KY, LA, MN, MO, NE, NJ, NM, NY, NC, OH, OK, PA, SD, TN, TX, UT, VA, WA, WV, WI and Internationally to: AUSTRALIA, AUSTRIA BELGIUM BOSNIA AND HERZEGOVINA, BRAZIL, CANADA, CHILE, COLOMBIA, CHINA, CROATIA, CZECH REPUBLIC, DENMARK, EGYPT, FRANCE, FINLAND, GEORGIA, GERMANY, HONG KONG, IRAN, ISRAEL INDIA,M ITALY, JAPAN, JORDAN, KUWAIT, LEBANON, MALAYSIA, MEXICO, MOROCCO, NEW ZEALAND, NORWAY, RUSSIA, REPUBLIC OF KOREA, POLAND, ROMANIA, SAUDI ARABIA, SPAIN, SWEDEN SWITZERLAND, TAIWAN, TUNISIA, THAILAND, TURKEY, UNITED KINGDOM.
- Recall number
- Z-0981-2014
- Recall status
- Terminated
- CDRH record ID
- 125293
- FDA classified
- 2014-02-14
- Recall event number
- 67343